Using genetics, bioinformatics, and RNA virology, FBB Biomed creates RNA-based diagnostic tests that personalize therapy for multiple sclerosis, viral epidemics, neuro-inflammatory diseases, autoimmune diseases, and cancers. Founded in 2019 and based in Coralville, Iowa, the company's technology addresses the market for laboratory-developed tests and the emerging market for RNA precision diagnostics.